Comparison of methods for control allocation in multiple arm studies using response adaptive randomization

Clinical Trials

Volumn 17, Issue 1, 2020, Pages 52-60

  Viele, Kert ^a   Broglio, Kristine ^a   McGlothlin, Anna ^a   Saville, Benjamin R ^a,b  

^a BERRY CONSULTANTS   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

control allocation; Multiple arm clinical trial; response adaptive randomization

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIMULATION; BENCHMARKING; COMPUTER SIMULATION; METHODOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STATISTICAL MODEL;

BENCHMARKING; COMPUTER SIMULATION; HUMANS; MODELS, STATISTICAL; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 85074429616     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774519877836     Document Type: Article

References (24)

1. Woodcock J, LaVange LM. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med 2017; 377(1): 62–70.
2. Freidlin B, Korn EL. Adaptive randomization versus interim monitoring. J Clin Oncol 2013; 31(7): 969–970.
3. Magirr D, Jaki T, Whitehead J. A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection. Biometrika 2012; 99(2): 494–501.
4. Trippa L, Lee E, Wen P, et al. Bayesian adaptive randomized trial design for patients with recurrent glioblastoma. J Clin Oncol 2013; 30(26): 3258–3263.
5. Hu F, Rosenberger W. The theory of response-adaptive randomization in clinical trials. Hoboken, NJ: John Wiley, 2006.
6. Thall P, Fox P, Wathen J. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials. Ann Oncol 2015; 26(8): 1621–1628.
7. Korn E, Freidlin B. Outcome-adaptive randomization: is it useful. J Clin Oncol 2011; 29(6): 771–776.
8. Berry D, Eick SG. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. Stat Med 1995; 14(3): 231–246.
9. Lee J. Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 110–112.
10. Hey S, Kimmelman J. Are outcome-adaptive allocation trials ethical. Clin Trials 2015; 12(2): 102–106.
11. Van der Graaf R, Roes KC, van Delden JJ. Adaptive trials in clinical research: scientific and ethical issues to consider. JAMA 2012; 307(22): 2379–2380.
12. Buyse M, Saad E, Burykowski T. Letter to the editor on adaptive randomization of neratinib in early breast cancer. N Engl J Med 2016; 375: 1591–1594.
13. Harrington D, Parmigiani G. I—SPY 2—a glimpse of the future of phase 2 drug development. N Engl J Med 2016; 375(1): 7–9.
14. Meinzer C, Martin R, Suarez JI. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization. Trials 2017; 18(1): 420.
15. Berry S, Petzold E, Dull P, et al. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: a model for pandemic response. Clin Trials 2016; 13(1): 22–30.
16. Connor J, Elm J, Broglio K. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol 2013; 66(8): S130–S137.
17. Lewis R, Viele K, Broglio K, et al. An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success. Crit Care Med 2013; 41(7): 1674–1678.
18. Alexander B, Ba S, Berger M, et al. Adaptive global innovative learning environment for glioblastoma: GBM AGILE. Clin Cancer Res 2018; 24(4): 737–743.
19. Lin J, Bunn V. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials. Contemp Clin Trials 2017; 54: 48–59.
20. Wason J, Trippa L. A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials. Stat Med 2014; 33(13): 2206–2221.
21. Wathen J, Thall P. A simulation study of outcome adaptive randomization in multi-arm clinical trials. Clin Trials 2017; 14(5): 432–440.
22. Jiang Y, Zhao W, Durkalski-Mauldin V. Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint. Contemp Clin Trials 2017; 62: 114–120.
23. London A. Learning health systems, clinical equipoise and the ethics of response adaptive randomisation. J Med Ethics 2018; 44(6): 409–415.
24. Dunnett C. A multiple comparison procedure for comparing several treatments with a control. J Amer Stat Assoc 1955; 50: 1096–1121.